Abstract: |
The PML gene of acute promyelocytic leukaemia (APL) encodes a cell growth and tumour suppressor, however, the mechanisms by which PML suppresses tumorigenesis are poorly understood. We show here that Pml is required for Fas- and caspase-dependent DNA-damage-induced apoptosis. We also found that Pml is essential for induction of programmed cell death by Fas, tumour necrosis factor α (TNF), ceramide and type I and II interferons (IFNs). As a result, Pml(-/-) mice and cells are protected from the lethal effects of ionizing radiation and anti-Fas antibody. Pml is required for caspase 1 and caspase 3 activation upon exposure to these stimuli. The PML-RARα fusion protein of APL renders haemopoietic progenitor cells resistant to Fas-, TNF- and IFN-induced apoptosis with a lack of caspase 3 activation, thus acting as a Pml dominant-negative product. These results demonstrate that Pml is a mediator of multiple apoptotic signals, and implicate inhibition of apoptosis in the pathogenesis of APL. |
Keywords: |
controlled study; unclassified drug; pathogenesis; nonhuman; alpha interferon; animal cell; mouse; animals; mice; mice, knockout; animal tissue; dna damage; apoptosis; cell growth; fas antigen; neoplasm proteins; caspase 3; enzyme activation; caspase; caspases; transcription factors; nuclear proteins; tumor suppressor gene; leukemia, promyelocytic, acute; tumor necrosis factor alpha; tumor necrosis factor-alpha; tumor suppressor proteins; acute myeloblastic leukemia; oncogene proteins, fusion; ionizing radiation; ceramide; ceramides; interleukin 1beta converting enzyme; antigens, cd95; gene isolation; intraperitoneal drug administration; concanavalin a; interferons; male; female; priority journal; article
|